SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001328143-21-000022
Filing Date
2021-02-23
Accepted
2021-02-23 16:15:20
Documents
4
Effectiveness Date
2021-02-23

Document Format Files

Seq Description Document Type Size
1 S-8 admss-82021filing.htm S-8 90233
2 EX-5.1 admss-82021ex51.htm EX-5.1 10438
3 EX-23.1 admss-82021ex231.htm EX-23.1 2436
4 image31.jpg GRAPHIC 10498
  Complete submission text file 0001328143-21-000022.txt   113374
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253396 | Film No.: 21665553
SIC: 2834 Pharmaceutical Preparations